Entity Common Stock, Shares Outstanding of Iterum Therapeutics plc from 31 Jul 2018 to 04 Aug 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Iterum Therapeutics plc quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jul 2018 to 04 Aug 2025.
  • Iterum Therapeutics plc Entity Common Stock, Shares Outstanding for the quarter ending 04 Aug 2025 was 44,656,906, a 97% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Iterum Therapeutics plc Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 44,656,906 +21,950,912 +97% 04 Aug 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 40,000,000 +23,445,115 +142% 12 May 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 34,581,405 06 Feb 2025 10-K 07 Feb 2025 2024 FY
Q3 2024 27,515,926 +14,465,919 +111% 04 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 22,705,994 +9,664,953 +74% 09 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 16,554,885 +3,612,504 +28% 30 Apr 2024 10-Q 13 May 2024 2024 Q1
Q3 2023 13,050,007 +816,633 +6.7% 31 Oct 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 13,041,041 -170,459,569 -93% 31 Jul 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 12,942,381 -170,411,037 -93% 30 Apr 2023 10-Q 12 May 2023 2023 Q1
Q3 2022 12,233,374 -170,541,908 -93% 31 Oct 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 183,500,610 +725,328 +0.4% 31 Jul 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 183,353,418 +4,214,649 +2.4% 30 Apr 2022 10-Q 13 May 2022 2022 Q1
Q3 2021 182,775,282 +139,740,037 +325% 31 Oct 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 182,775,282 +161,536,189 +761% 31 Jul 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 179,138,769 +164,269,796 +1105% 30 Apr 2021 10-Q 14 May 2021 2021 Q1
Q3 2020 43,035,245 +28,166,272 +189% 31 Oct 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 21,239,093 +6,814,669 +47% 31 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 14,868,973 +499,755 +3.5% 30 Apr 2020 10-Q 14 May 2020 2020 Q1
Q3 2019 14,868,973 +709,550 +5% 31 Oct 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 14,424,424 +265,001 +1.9% 31 Jul 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 14,369,218 30 Apr 2019 10-Q 14 May 2019 2019 Q1
Q3 2018 14,159,423 31 Oct 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 14,159,423 31 Jul 2018 10-Q 14 Aug 2018 2018 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.